MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.98
-0.21 (-1.09%)
At close: Jun 16, 2026, 4:00 PM EDT
19.01
+0.03 (0.16%)
After-hours: Jun 16, 2026, 6:23 PM EDT

MLTX Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, MLTX stock has a consensus rating of "Buy" and an average price target of $27.62. The average 1-year stock price forecast is 45.52% higher than the current stock price, while the lowest is $6.00 (-68.39%) and the highest is $46 (+142.36%).

Price Target: $27.62 (+45.52%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$6.00$27.62$30$46
Change-68.39%+45.52%+58.06%+142.36%

Analyst Ratings

The average analyst rating for MLTX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy9911111010
Buy111111
Hold432222
Sell000000
Strong Sell332222
Total171616161515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Needham
Needham
Buy
Maintains
$30
BuyMaintains$30+58.06%Jun 8, 2026
Wedbush
Wedbush
Buy
Maintains
$34
BuyMaintains$34+79.14%Jun 8, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$45
BuyReiterates$45+137.09%Jun 8, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$33
BuyMaintains$33+73.87%May 19, 2026
BTIG
BTIG
Buy
Reiterates
$30
BuyReiterates$30+58.06%May 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
19.44M
EPS This Year
-3.86
from -3.53
EPS Next Year
-3.45
from -3.86
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------
Operating Income
-34.29M-65.06M-54.12M-143.09M-244.83M-281.64M
Net Income
-64.37M-49.97M-36.01M-118.94M-227.32M-288.80M
EPS
-----3.53-3.86
Free Cash Flow
--32.23M-24.14M-92.06M-120.38M-216.00M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-3.25
Avg-3.86
Low-5.16

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-